Form 4: iSpecimen Inc. Director Elizabeth Ames Graham Acquires Stock Options

Director Elizabeth Ames Graham reports acquisition of 8,340 iSpecimen Inc. stock options on March 21, 2024.

Summary

• Elizabeth Ames Graham, a director of iSpecimen Inc. (ISPC), filed a Form 4 on May 20, 2024, reporting a transaction.
• On March 21, 2024, Graham acquired 8,340 stock options at a price of $0.28 per option.
• These options are directly owned and exercisable for common stock.
• The options vest in four equal installments of 2,085 shares on March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024.
• Following the transaction, Graham beneficially owns 8,340 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants, which is neither particularly positive nor negative.

Positives

• The acquisition of stock options by a director may signal confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule indicates continued involvement of the director.

Industry Context

This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency to investors regarding the holdings and transactions of company insiders.

Comparison to Industry Standards

• Stock option grants are a common form of compensation for directors and executives in publicly traded companies.
• The vesting schedule of the options is fairly standard, with quarterly vesting over a one-year period.
• The exercise price of $0.28 would need to be compared to the market price of ISPC stock at the time of the grant to assess its value.

Stakeholder Impact

• Shareholders are informed about the stock option grants to a director, providing transparency into insider compensation.

Key Dates

Keywords

iSpecimen Inc., ISPC, Elizabeth Ames Graham, stock options, Form 4, director, beneficial ownership, securities